Skip to main content

Table 2 Characteristic of 76 adults with HIV treated for pulmonary tuberculosis, Jos, Nigeria (June 2013– June 2015)

From: Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study

Characteristics Xpert MTB Detected
(n = 56)
Xpert No MTB
Detected (n = 20)
P-value
Age, years,Mean (SD) 37.3 (13.2) 35.0 (12.3) 0.39
Sex    0.004
 Male, n (%) 32 (57.1) 4 (20.0)  
 Female, n (%) 24 (42.9) 16 (80)  
TB symptoms    
 Cough > 2 weeks, n (%) 42 (75.0) 14 (70.0) 0.66
 Fever, n (%) 48 (85.7) 14 (70.0) 0.12
 Weight loss, n (%) 52 (92.9) 15 (75.0) 0.03
 Night Sweat, n (%) 45 (80.4) 11 (55) 0.03
Previous TB treatment, n (%) 7 (12.5) 4 (20) 0.4
On ART, n (%) 48 (88.9) 15 (83.3) 0.54
Current CD4 ≤ 200 cells/mm3,n (%) 38 (67.9) 10 (50.0) 0.16
aCD4 count at TB diagnosis, cells/mm3, Median (IQR) 198 (68–354) 309 (123–507) 0.09
SM positive, n (%) 50 (89.3) 7 (35.0) <0.001
Rifampicin Resistance, n (%) 5 (8.93) - -
  1. SD Standard deviation, IQR Interquartile range, TB Tuberculosis, MTB Mycobacterium tuberculosis, ART Antiretroviral Therapy, SM Sputum smear microscopy for acid fast bacilli aKruskal Wallis test